In a groundbreaking study that sheds light on the intricate interplay between immune cells and cancer therapy resistance, researchers have unveiled how M2 polarization of macrophages can shield lung cancer cells from the lethal effects of cold atmospheric plasma (CAP) treatment.
English (US) ·